✦ LIBER ✦

Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo

✍ Scribed by Robert J. Schmidt; Thomas P. Beyer; William R. Bensch; Yue-Wei Qian; Aiming Lin; Mark Kowala; William E. Alborn; Robert J. Konrad; Guoqing Cao

Book ID: 116296681
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 433 KB
Volume: 370
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2008.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum levels of proprotein convertase su

Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathways

✍ Jamie Cameron; Martin P. Bogsrud; Kristian Tveten; Thea Bismo StrØm; Kirsten Hol 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Affinity and kinetics of proprotein conv

Affinity and kinetics of proprotein convertase subtilisin/kexin type 9 binding to low-density lipoprotein receptors on HepG2 cells

✍ Seyed A. Mousavi; Knut E. Berge; Trond Berg; Trond P. Leren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 259 KB

Fenofibrate concomitantly decreases seru

Fenofibrate concomitantly decreases serum proprotein convertase subtilisin/kexin type 9 and very-low-density lipoprotein particle concentrations in statin-treated type 2 diabetic patients

✍ D. C. Chan; S. J. Hamilton; K. A. Rye; G. T. Chew; A. J. Jenkins; G. Lambert; G. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB